Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease: findings based on urine proteomics and machine learning

BACKGROUND: Alzheimer’s disease is a prevalent disease with a heavy global burden. Proteomics is the systematic study of proteins and peptides to provide comprehensive descriptions. Aiming to obtain a more accurate and convenient clinical diagnosis, researchers are working for better biomarkers. Uri...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuye, Sun, Yu, Wang, Yu, Jia, Shuhong, Qiao, Yanan, Zhou, Zhi, Shao, Wen, Zhang, Xiangfei, Guo, Jing, Zhang, Bin, Niu, Xiaoqian, Wang, Yi, Peng, Dantao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625308/
https://www.ncbi.nlm.nih.gov/pubmed/37925455
http://dx.doi.org/10.1186/s13195-023-01324-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625308/
https://www.ncbi.nlm.nih.gov/pubmed/37925455
http://dx.doi.org/10.1186/s13195-023-01324-4

Ejemplares similares